Global Digital Biology Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Digital Biology Market Research Report 2024
Digital biology is the study of the fundamental computation performed by biological processes, from gene regulatory systems to ecosystems and from neural networks to swarming systems.
According to MRA Research’s new survey, global Digital Biology market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Digital Biology market research.
Key companies engaged in the Digital Biology industry include DUNA Bioinformatics, Precigen (Intrexon Corporation), Dassault Systèmes, Genedata AG and Simulations Plus, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of Digital Biology were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole Digital Biology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Digital Biology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
DUNA Bioinformatics
Precigen (Intrexon Corporation)
Dassault Systèmes
Genedata AG
Simulations Plus, Inc.
Segment by Type
Cellular & Biological Simulation
Drug Discovery & Disease Modelling
Preclinical Drug Development
Clinical Trials
Human Body Simulation Software
In-house
Contract
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Digital Biology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRA Research’s new survey, global Digital Biology market is projected to reach US$ million in 2033, increasing from US$ million in 2023, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Digital Biology market research.
Key companies engaged in the Digital Biology industry include DUNA Bioinformatics, Precigen (Intrexon Corporation), Dassault Systèmes, Genedata AG and Simulations Plus, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2023.
When refers to consumption region, % value of Digital Biology were sold to North America, Europe and Asia Pacific in 2023. Moreover, China, plays a key role in the whole Digital Biology market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Digital Biology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
DUNA Bioinformatics
Precigen (Intrexon Corporation)
Dassault Systèmes
Genedata AG
Simulations Plus, Inc.
Segment by Type
Cellular & Biological Simulation
Drug Discovery & Disease Modelling
Preclinical Drug Development
Clinical Trials
Human Body Simulation Software
Segment by Application
In-house
Contract
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Digital Biology report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source